p.82 抽出テキスト
CLINICAL STATEMENTS AND GUIDELINES Circulation. 2025;152:e114–e218. DOI: 10.1161/CIR.0000000000001356 September 16, 2025 e195 47 Guo JW, Ning H, Allen NB, et al. Association of cardiovascular health in young adulthood with long-term blood pressure trajectories. Am J Hyper tens. 2024;37:667–673. 48. Cook NR, Appel LJ, Whelton PK. Lower levels of sodium intake and re duced cardiovascular risk. Circulation. 2014;129:981–989. 49. Cook NR, Cutler JA, Obarzanek E, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observation al follow-up of the trials of hypertension prevention (TOHP). BMJ. 2007;334:885–888. 50. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–163. 51. Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22 Suppl 3:1–203. 52. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129(suppl 2):s102–s138. 53. Schiavon CA, Bersch-Ferreira AC, Santucci EV, et al. Effects of bariatric surgery in obese patients with hypertension the GATEWAY randomized trial (gastric bypass to treat obese patients with steady hypertension). Circula tion. 2018;137:1132–1142. 54. Siebenhofer A, Winterholer S, Jeitler K, et al. Long-term effects of weightreducing drugs in people with hypertension. Cochrane Database Syst Rev. 2021;1:Cd007654. 55. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989–1002. 56. Khera R, Pandey A, Chandar AK, et al. Effects of weight-loss medications on cardiometabolic risk profiles: a systematic review and network metaanalysis. Gastroenterology. 2018;154:1309–1319.e1307. 57. LeBlanc ES, Patnode CD, Webber EM, et al. Behavioral and pharmaco therapy weight loss interventions to prevent obesity-related morbidity and mortality in adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;320:1172–1191. 58. Iqbal J, Wu HX, Hu N, et al. Effect of glucagon-like peptide-1 receptor agonists on body weight in adults with obesity without diabetes mellitus-a systematic review and meta-analysis of randomized control trials. Obes Rev. 2022;23:e13435. 59. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387:205–216. 60. de Lemos JA, Linetzky B, le Roux CW, et al. Tirzepatide reduces 24-hour ambulatory blood pressure in adults with body mass index ≥27 kg/m(2): SURMOUNT-1 ambulatory blood pressure monitoring substudy. Hyperten sion. 2024;81:e41-e43. 61. Jama HA, Snelson M, Schutte AE, et al. Recommendations for the use of di etary fiber to improve blood pressure control. Hypertension. 2024;81:1450– 1459. 62. Abbasnezhad A, Falahi E, Gonzalez MJ, et al. Effect of different dietary approaches compared with a regular diet on systolic and diastolic blood pressure in patients with type 2 diabetes: A systematic review and metaanalysis. Diabetes Res Clin Pract. 2020;163:108108. 63. Siervo M, Lara J, Chowdhury S, et al. Effects of the Dietary Approach to Stop Hypertension (DASH) diet on cardiovascular risk factors: a systematic review and meta-analysis. Br J Nutr. 2015;113:1–15. 64. Gay HC, Rao SG, Vaccarino V, et al. Effects of different dietary interventions on blood pressure: systematic review and meta-analysis of randomized con trolled trials. Hypertension. 2016;67:733–739. 65. Howard G, Cushman M, Moy CS, et al. Association of clinical and social fac tors with excess hypertension risk in Black compared with White US adults. JAMA. 2018;320:1338–1348. 66. Svetkey LP, Simons-Morton D, Vollmer WM, et al. Effects of dietary pat terns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med. 1999;159:285–293. 67. Following the DASH eating plan. National Heart, Lung, and Blood Institute. Accessed July 2, 2024. https://www.nhlbi.nih.gov/education/dash/follow ing-dash. 68. What is the DASH diet? Accessed July 2, 2024. https://dashdiet.org/whatis-the-dash-diet.html. 69. Your guide to lowering your blood pressure with DASH. National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/files/docs/public/ heart/new_dash.pdf. 70 Riegel GR, Ribeiro PAB, Rodrigues MP, et al. Efficacy of nutritional rec ommendations given by registered dietitians compared to other healthcare providers in reducing arterial blood pressure: systematic review and metaanalysis. Clin Nut. 2018;37:522–531. 71. Bazzano LA, Hu T, Reynolds K, et al. Effects of low-carbohydrate and lowfat diets: a randomized trial. Ann Intern Med. 2014;161:309–318. 72. He J, Wofford MR, Reynolds K, et al. Effect of dietary protein supple mentation on blood pressure: a randomized, controlled trial. Circulation. 2011;124:589–595. 73. Nordmann AJ, Suter-Zimmermann K, Bucher HC, et al. Meta-analysis com paring Mediterranean to low-fat diets for modification of cardiovascular risk factors. Am J Med. 2011;124:841–851.e842. 74. Yokoyama Y, Nishimura K, Barnard ND, et al. Vegetarian diets and blood pressure: a meta-analysis. JAMA Intern Med. 2014;174:577–587. 75. Gholizadeh-Moghaddam M, Shahdadian F, Shirani F, et al. The effect of a low versus high sodium diet on blood pressure in diabetic patients: a systematic review and meta-analysis of clinical trials. Food Sci Nutr. 2023;11:1622– 1633. 76. Gupta DK, Lewis CE, Varady KA, et al. Effect of dietary sodium on blood pressure: a crossover trial. JAMA. 2023;330:2258–2266. 77. Huang L, Trieu K, Yoshimura S, et al. Effect of dose and duration of reduc tion in dietary sodium on blood pressure levels: systematic review and metaanalysis of randomised trials. BMJ. 2020;368:m315. 78. Khalesi S, Williams E, Irwin C, et al. Reducing salt intake: a systematic re view and meta-analysis of behavior change interventions in adults. Nutr Rev. 2022;80:723–740. 79. Lai JS, Aung YN, Khalid Y, et al. Impact of different dietary sodium reduc tion strategies on blood pressure: a systematic review. Hypertens Res. 2022;45:1701–1712. 80. Ren J, Qin L, Li X, et al. Effect of dietary sodium restriction on blood pres sure in type 2 diabetes: a meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2021;31:1653–1661. 81. Vargas-Meza J, Gonzalez-Rocha A, Campos-Nonato I, et al. Effective and scalable interventions to reduce sodium intake: a systematic review and meta-analysis. Curr Nutr Rep. 2023;12:486–494. 82. Xun R, Gao Y, Zhen S, et al. Effects of behavioral interventions for salt re duction on blood pressure and urinary sodium excretion: a systematic review and meta-analysis of randomized controlled trials. Glob Heart. 2023;18:65. 83. Yan YY, Chan LML, Wang MP, et al. Technology-supported behavior change interventions for reducing sodium intake in adults: a systematic review and meta-analysis. NPJ Digit Med. 2024;7:72. 84. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ. 1988;297:319–328. 85. Stamler J. The INTERSALT study: background, methods, findings, and impli cations. Am J Clin Nutr. 1997;65:626S-642S. 86. Bailey MA, Dhaun N. Salt sensitivity: causes, consequences, and recent ad vances. Hypertension. 2024;81:476–489. 87. Barris CT, Faulkner JL, Belin de Chantemele EJ. Salt sensitivity of blood pressure in women. Hypertension. 2023;80:268–278. 88. Weinberger MH, Miller JZ, Luft FC, et al. Definitions and characteris tics of sodium sensitivity and blood pressure resistance. Hypertension. 1986;8:Ii127-Ii134. 89. Mattes RD, Donnelly D. Relative contributions of dietary sodium sources. J Am Coll Nutr. 1991;10:383–393. 90. Ahmed M, Ng AP, Christoforou A, et al. Top sodium food sources in the American diet-using National Health and Nutrition Examination Survey. Nu trients. 2023;15:831. 91. US Department of Agriculture and US Department of Health and Hu man Services. Dietary Guidelines for Americans, 2020-2025. 9th Edition. December 2020. https://www.dietaryguidelines.gov/resources/2020- 2025-dietary-guidelines-online-materials. 92. Bibbins-Domingo K, Chertow GM, Coxson PG, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010;362:590–599. 93. Tsai YC, Tsao YP, Huang CJ, et al. Effectiveness of salt substitute on cardio vascular outcomes: a systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2022;24:1147–1160. 94. Yin X, Rodgers A, Perkovic A, et al. Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis. Heart. 2022;108:1608– 1615. 95. Li Y, Zhang P, Wu J, et al. Twenty-four-hour urinary sodium and potassium excretion and their associations with blood pressure among adults in China. Hypertension. 2020;76:1580–1588. Downloaded from http://ahajournals.org by on October 7, 2026